Table 1 Clinical, surgical, pathological and inflammatory parameters for the study population
N (%) or mean ± SD or median (range) | |
|---|---|
Males | 268 (81.3%) |
Age (years) | 62.9 ± 8.7 |
Smoker | 205 (76.5%) |
Diabetes mellitus | 57 (21.3%) |
Ischaemic cardiomyopathy | 33 (12.3%) |
COPD | 100 (37.3%) |
Hypertension | 103 (38.4%) |
Dyslipidaemia | 99 (36.9%) |
Surgical procedure | |
Lobectomy | 224 (83.6%) |
Pneumonectomy | 14 (5.2%) |
Sub-lobar resection | 38 (11.2%) |
Pathologic stage | |
Ia/Ib | 173 (64.5%) |
IIa/IIb | 74 (27.6%) |
IIIa/IIIb | 19 (7.1%) |
IV | 2 (0.8%) |
Histological type | |
Adenocarcinoma | 168 (62.7%) |
Squamous cell carcinoma | 79 (29.5%) |
Large cell carcinoma | 18 (6.7%) |
Other | 3 (1.1%) |
Neutrophils, × 109/L | 4.47 (1.63) |
Lymphocytes, × 109/L | 2.14 (1.59) |
Monocytes, × 109/L | 0.57 (0.20) |
Platelets, × 109/L | 243 (79.71) |
LMR | 3.97 (1.97) |
NLR | 2.38 (1.23) |
PLR | 131.59 (65.03) |